Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP vs DA-EPOCH-R in Untreated DLBCL
NCT00118209Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 2005
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide in diffuse large B-cell lymphoma (DLBCL), sponsored by Cancer and Leukemia Group B. Started May 2005; status: completed.
02
Drugs
etoposide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00118209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118209.